295 related articles for article (PubMed ID: 27317941)
1. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area.
Im JH; Yoon SM; Park HC; Kim JH; Yu JI; Kim TH; Kim JW; Nam TK; Kim K; Jang HS; Kim JH; Kim MS; Yoon WS; Jung I; Seong J
Liver Int; 2017 Jan; 37(1):90-100. PubMed ID: 27317941
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.
Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q
Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis.
Rim CH; Yang DS; Park YJ; Yoon WS; Lee JA; Kim CY
Jpn J Clin Oncol; 2012 Aug; 42(8):721-9. PubMed ID: 22689916
[TBL] [Abstract][Full Text] [Related]
4. Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Jeong Y; Yoon SM; Han S; Shim JH; Kim KM; Lim YS; Lee HC; Kim SY; Park JH; Lee SW; Ahn SD; Choi EK; Kim JH
PLoS One; 2015; 10(8):e0135298. PubMed ID: 26252472
[TBL] [Abstract][Full Text] [Related]
5. Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis.
Wang K; Guo WX; Chen MS; Mao YL; Sun BC; Shi J; Zhang YJ; Meng Y; Yang YF; Cong WM; Wu MC; Lau WY; Cheng SQ
Medicine (Baltimore); 2016 Mar; 95(11):e3015. PubMed ID: 26986115
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.
Okazaki E; Yamamoto A; Nishida N; Hamuro M; Ogino R; Hosono M; Shimatani Y; Tsutsumi S; Hamamoto S; Sohgawa E; Jogo A; Miki Y
Br J Radiol; 2016 Jul; 89(1063):20150945. PubMed ID: 27164029
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram.
Li X; Ye Z; Lin S; Pang H
BMC Cancer; 2021 Jun; 21(1):701. PubMed ID: 34126955
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
[TBL] [Abstract][Full Text] [Related]
10. Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy.
Yu JI; Park HC; Lim DH; Park W; Yoo BC; Paik SW; Koh KC; Lee JH
J Korean Med Sci; 2011 Aug; 26(8):1014-22. PubMed ID: 21860551
[TBL] [Abstract][Full Text] [Related]
11. Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis.
Nakazawa T; Hidaka H; Shibuya A; Okuwaki Y; Tanaka Y; Takada J; Minamino T; Watanabe M; Kokubu S; Koizumi W
BMC Gastroenterol; 2014 May; 14():84. PubMed ID: 24886354
[TBL] [Abstract][Full Text] [Related]
12. Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy.
Choi Y; Kim JW; Cha H; Han KH; Seong J
J Radiat Res; 2014 Jan; 55(1):113-20. PubMed ID: 23772086
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis.
Yu JI; Park HC
World J Gastroenterol; 2016 Aug; 22(30):6851-63. PubMed ID: 27570422
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis.
Chen MY; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Tsang NM; Chan KM; Lee WC
Biomed Res Int; 2016; 2016():6017406. PubMed ID: 27999803
[No Abstract] [Full Text] [Related]
16. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study.
Yu JI; Park JW; Park HC; Yoon SM; Lim DH; Lee JH; Lee HC; Kim SW; Kim JH
Radiother Oncol; 2016 Feb; 118(2):408-15. PubMed ID: 26830695
[TBL] [Abstract][Full Text] [Related]
18. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
[TBL] [Abstract][Full Text] [Related]
19. Portal vein tumour thrombosis radiotherapy improves the treatment outcomes of immunotherapy plus bevacizumab in hepatocellular carcinoma: a multicentre real-world analysis with propensity score matching.
Tang C; He Q; Feng J; Liao Z; Peng Y; Gao J
Front Immunol; 2023; 14():1254158. PubMed ID: 37928530
[TBL] [Abstract][Full Text] [Related]
20. Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?
Srivastava A; Parambath HK; Ramdulari AV; Saxena H; Kumar R; Pandey S; Shalimar ; Gupta S; Jee B
Int J Radiat Biol; 2022; 98(10):1495-1509. PubMed ID: 35311612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
